Dr. Wasana Sumanasekera received her Ph. D. from Pennsylvania State University in 2003. For her thesis, she has investigated the Peroxisome Proliferator Activated Receptor (PPAR) signaling, PPAR associated proteins, and different PPAR subtypes. Upon graduation, Dr. Sumanasekera joined the Department of Biochemistry and Molecular Biology, University of Louisville as a post-doctoral scientist. After 2 months, she has been awarded the American Heart Association postdoctoral fellowship (2003-2006) as the principal

Prof. Qian Zhong Ming graduated from Suzhou Medical School in 1978, received his Master Degree in Medicine at Peking University (Beijing Medical University) of PRC in 1981 and Ph.D. in Medical Physiology at the Medical School of the University of Western Australia, Australia, in 1993

Dr. Morshed Nasir is a professor and Head of the department with history of working on the drug safety, rational prescribing practice, infectious diseases, analgesics, mental health care and arsenicosis. Experienced senior faculty member with diverse background in Pharmacology and Therapeutics in research and teaching of undergraduate and postgraduate medical study. Skilled in public health research, management, occupational health, healthcare, and pharmacovigilance. Strong educational and professional accomplishment from BSM Medical University, University of Chittagong.

Dr. Hanganu Daniela joined the Department of Pharmacognosy, Faculty of Pharmacy, in 1993 for my Doctoral thesis. In June 1997. His thesis The pharmacognostical analysis of Chrysanthemum balsamita L. (Asteraceae). In 2002, He graduated a Postdoctoral stage in the Ethnopharmacological Field at the University of Metz in collaboration with France Society of Ethnopharmacology. Currently, He is the vice-president of Romanian Society of Ethnopharmacology and was a specialist on phytochemistry. His research includes the field of medicinal plants, obtaining, characterization and standardization of extracts, testing their pharmacological action, testing antioxidant activity in vitro and in vivo, analysis and isolation of biologically active compounds (polyphenols, carotenoids, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

Nowaday, He is also working as  a pharmacist, Associate Professor PhD. at University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca (Romania), Department of Pharmacognosy (Faculty of Pharmacy). His work is embodied in scientific papers: 10 books published in national publishing houses: CNCSIS-MECI, 5 chapters published in books, 105 scientific papers published in journals.He have been involved in 10 research projects (as member or as manager).He is a member of the professional associations: Association of Romanian Pharmacists, Society of Pharmaceutical Sciences of Romania, Association for the Medicinal and Aromatic Plants of Southeast European Countries (AMAPSEC), Society for Medicinal Plant and Natural Product Research (GA) and Vice President of Romanian Society of Ethnopharmacology.

In a 16-year career, Dr. Gerald Lushington has collaborated on diverse research in drug discovery, molecular biology, chemical synthesis, data mining, and other fields. He has directly supported 29 funded projects in roles ranging from principal investigator, core lead to consultant. Various federal agencies such as the NIH and DOD have supported Lushington's work. Dr. Lushington's research has produced more than 180 peer-reviewed papers, and a Hindex of 38. Serving on multiple external advisory boards, He is Editor for informatics in the journal Combinatorial Chemistry & High Throughput Screening, bioinformatics editor for WebMedCentral, and sits on editorial boards of The Open Enzyme Inhibition Journal, Current Bioactive Compounds, and the Journal of Clinical Bioinformatics. He has reviewed proposals for the U.S. Civilian Research and Development Foundation, the U.S. Defense Threat Reduction Agency, and the Czech Science Foundation. For more than a decade, Gerry Lushington served as a Lab Director at the University of Kansas, in Lawrence, where he managed the technologies in support of scientists, and secured and administered consulting projects with multiple corporations, including Cydex Pharmaceuticals, Inc., Sidley Austin, LLP, and Vanda Pharmaceuticals, Inc. Lushington trained clients on the facility's equipment, configured computational systems, and wrote scientific protocols and analyses. His work there produced a high-performance computational lab comprising 40 cluster processors, six data servers, and 10 work stations supporting a diverse range of modeling and analysis applications. Since mid-2012, Dr. Gerry Lushington has led an independent consultancy, Lushington in Silico, conducting simulation, data analysis, graphics and technical writing services. One of the firm's nine current clients is actively pursuing the commercialization of technology coinvented and patented by Lushington. Since June 2020, Lushington’s primary effort has focused on co-founding a new pharmaceutical startup, Qnapsyn Inc., with a broad pipeline of prospective new therapeutics aimed at metabolic, autoimmune and neurological targets.

Jesper Bo Nielsen (JBN) has for the last 14 years chaired the Institute of Public Health. JBN has now the overall responsibility for staff (>250 employees), economy (annual turnaround >130 million Kroner), research (8 research units plus a few research centers), teaching (3 educations with main responsibility besides participation in 5-6 other educations), and administration. During JBNs time in office, the Institute has received more than 850 million Kroner in external research grants, and strategic collaborations with neighbor institutions have been strengthened through affiliation agreements. During the leadership of JBN, the first Max Planck Center in the Nordic Countries was opened in 2013 and affiliated to the Institute.

Over the recent years, Jesper Bo Nielsen has attracted substantial funding and initiated independent research projects within areas such as dermal absorption, medical risk analysis, risk communication, medical decision making, and development and use of decision aids. The latter four themes related to the interaction between citizen, patient and health care professionals with a focus on risk behavior, communication, barriers and incitements, and decision aids.

Hanaa Salem Saleh Gazwi, Biochemistry Demonstrator and Department of Agricultural Chemistry at Minia University from 2010-2012. She served as an Assistant lecturer in Biochemistry, Department of Agricultural Chemistry at Minia University from 2012-2016 and is currently a lecturer in Biochemistry, Department of Agricultural Chemistry at Minia University from 2016-to date.